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Abstract
Background: Lipoprotein receptors from the low density lipoprotein (LDL) receptor family are multifunctional membrane
proteins which can efficiently mediate endocytosis and thereby facilitate lipoprotein clearance from the plasma. The biggest
member of this family, the LDL receptor-related protein 1 (LRP1), facilitates the hepatic uptake of triglyceride-rich
lipoproteins (TRL) via interaction with apolipoprotein E (apoE). In contrast to the classical LDL degradation pathway, TRL
disintegrate in peripheral endosomes, and core lipids and apoB are targeted along the endocytic pathway for lysosomal
degradation. Notably, TRL-derived apoE remains within recycling endosomes and is then mobilized by high density
lipoproteins (HDL) for re-secretion. The aim of this study is to investigate the involvement of LRP1 in the regulation of apoE
recycling.
Principal Findings: Immunofluorescence studies indicate the LRP1-dependent trapping of apoE in EEA1-positive
endosomes in human hepatoma cells. This processing is distinct from other LRP1 ligands such as RAP which is efficiently
targeted to lysosomal compartments. Upon stimulation of HDL-induced recycling, apoE is released from LRP1-positive
endosomes but is targeted to another, distinct population of early endosomes that contain HDL, but not LRP1. For
subsequent analysis of the recycling capacity, we expressed the full-length human LRP1 and used an RNA interference
approach to manipulate the expression levels of LRP1. In support of LRP1 determining the intracellular fate of apoE,
overexpression of LRP1 significantly stimulated HDL-induced apoE recycling. Vice versa LRP1 knockdown in HEK293 cells
and primary hepatocytes strongly reduced the efficiency of HDL to stimulate apoE secretion.
Conclusion: We conclude that LRP1 enables apoE to accumulate in an early endosomal recycling compartment that serves
as a pool for the intracellular formation and subsequent re-secretion of apoE-enriched HDL particles.
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Introduction
TRL, namely intestinal chylomicrons (CM) and liver-derived
very low density lipoproteins (VLDL), deliver dietary and
endogenous lipids through the bloodstream where fatty acids are
liberated from triglycerides (TG) by the action of lipoprotein lipase
(LPL). It is well established that released fatty acids are taken up by
peripheral organs such as muscle, heart and white adipose tissue
for energy storage or combustion [1]. Recently we showed that
also activated brown adipose tissue drastically accelerates the
clearance of triglycerides, a process crucially dependent on local
LPL activity [2]. During lipolysis TRL remnant particles become
enriched with HDL-derived apoE, and LPL remains associated
with these particles (for review see [3]). These TRL remnants are
rapidly cleared by the liver in an insulin-dependent manner via
binding of apoE and LPL to LRP1 or heparan sulfate
proteoglycans (HSPG) [4–9]. VLDL remnants are cleared via
apoB100 and apoE binding to the LDL receptor (LDLR) (for
review see [3,10]). These processes involve an initial binding of
TRL to HSPG or the scavenger receptor class B, type I (SRBI)
before subsequent LDLR- and LRP1-mediated internalization
[11,12].
After receptor-mediated endocytosis the intracellular processing
of TRL is quite complex and distinct from the classical LDL
pathway. It could be demonstrated earlier that TRL disintegrate
in peripheral endosomes, followed by a differential sorting of TRL
components [13–16]. The majority of TRL lipids are targeted to
lysosomes, whereas TRL-derived apoE and cholesterol accumu-
late in peripheral recycling endosomes [17]. Substantial amounts
of TRL-derived apoE are then recycled back to the cell surface, re-
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showed that HDL stimulated apoE recycling serves as an acceptor
for TRL-derived apoE [15,17,18]. This process is associated with
cholesterol efflux in hepatocytes and fibroblasts, and involves the
internalization of HDL to endosomes containing TRL-derived
apoE [17]. Most intriguingly, HDL-induced recycling of TRL-
derived apoE4 is impaired compared to apoE3. Furthermore,
reduced apoE4 recycling is associated with a decrease in
cholesterol efflux in hepatocytes and fibroblasts [19]. However
apoE4 recycling seems not to be linked to cholesterol efflux in
neuronal cell lines [20]. Given the different metabolic properties of
apoE isoforms, these findings could possibly be related to the
development of atherosclerosis and Alzheimer’s disease [3,21,22].
The role of lipoprotein receptors in TRL uptake and endosomal
trafficking of TRL-derived apoE has been investigated in several
studies [6,7,11,12,14,16,23]. However, little is known about the
involvement of LRP1 in the regulation of apoE recycling. Since
the secretion of TRL-derived apoE is not impaired in FH (familial
hypercholesterolemia) fibroblasts lacking LDLR, we suggested that
LRP1 might be responsible for the recycling process [13].
Moreover, LRP1 is essential for endocytosis and re-presentation
of chaperoned peptides in antigen-presenting cells, providing a
model of LRP1 targeting ligands into specialized endocytic
compartments involved in re-secretion [24,25]. On the other
hand, the lysosomal targeting of LRP1 ligands such as the receptor
associated protein (RAP) and activated a2-macroglobulin (a2M*)
has been extensively used to study the role of LRP1 in the
degradative pathway [26,27]. Thus multiple ligands of LRP1
[28,29] are targeted to different cellular compartments suggesting
that specific binding affinities of the various ligands for LRP1
determine their intracellular destination.
In this study, we demonstrate that internalized TRL-derived
apoE accumulates in LRP1 containing early endosomes, whereas
RAP is targeted to (pre)-lysosomal compartments. Upon stimula-
tion of HDL-induced recycling, apoE is no longer associated with
LRP1-positive endosomes but targeted to LRP1-deficient, HDL-
containing endosomes. LRP1 overexpression significantly stimu-
lates HDL-induced apoE recycling, whereas down-regulation of
LRP1 reduces the ability of HDL to promote apoE secretion. We
conclude that LRP1 targets apoE into early endosomal recycling
compartments to facilitate the intracellular formation and
subsequent re-secretion of apoE enriched HDL particles.
Results
Intracellular localization of LRP1 and differential sorting
of apoE and RAP
LRP1 has been shown to facilitate hepatic clearance of TRL.
However, only a small proportion of LRP1 is present at the cell
surface, whereas the majority of the receptor is found in
intracellular, potentially endosomal compartments [7,30]. To
clarify the cellular localization of LRP1 in liver cells, we performed
co-localization studies in human HuH7 hepatoma cells (Fig. 1). In
agreement with previous findings, large amounts of LRP1 are
Figure 1. Endogenous LRP1 colocalizes with early endosomes markers. LRP1 was co-stained with LAMP-1 (A–C), the Golgi marker G58K (D–
F) and EEA1 (G–I) in human hepatoma cells (HuH7) using respective antibodies. Confocal microscopy demonstrated a strong colocalization of LRP1
with the early endosome marker EEA1 in punctate peripheral and perinuclear endosomal structures (see arrows in the merged image, panel I). Nuclei
appear in blue. Bar is 20 mm.
doi:10.1371/journal.pone.0029385.g001
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compartments (Fig. 1A, D and G). Importantly, LRP1 is not found
in late endosomes or the Golgi-complex, as evidenced by the lack
of colocalization with LAMP-1 (Fig. 1A–C) and the Golgi marker
protein G58K (Fig. 1D–F), respectively, but it co-localizes with
EEA1, a marker for early endosomes (Fig. 1G–I). Thus, in liver
cells the major pool of LRP1 proteins is localized in the early
endosomal compartment. To analyse if LRP1 is associated with
internalized apoE in early endosomes we compared the intracel-
lular localization of internalized and fluorescence-labelled apoE-
TRL (Cy5-apoE-TRL) and RAP (Cy3-RAP) with LRP1. The
efficiency and integrity of fluorescence-labelling of apoE-TRL and
RAP was confirmed by SDS-PAGE and subsequent in-gel
fluorescence detection (Fig. 2A). As shown previously, upon
incubation of HuH7 hepatoma cells with Cy5-apoE-TRL,
fluorescently labelled apoE is efficiently internalized (Fig. 2B–C)
and appears within widely distributed peripheral endosomal
compartments [17]. TRL-derived apoE is predominantly found
in EEA1- and LRP1-positive endocytic vesicles 10 min (Fig. 3A–
D) and 30 min (Fig. 4A–C) after incubation with Cy5-apoE-TRL
indicating that substantial amounts of apoE are internalized via
LRP1-mediated endocytosis and remains associated with LRP1.
As shown previously [13], endocytosed apoE-TRL does not
colocalize with LAMP-1 in (pre)-lysosomes (Fig. 4D–F). In
contrast, RAP is efficiently delivered to lysosomal compartments
under these conditions (Fig. 4G–I). These findings indicate that
during TRL disintegration in early peripheral endosomes, apoE
remains associated with LRP1 in EEA1-positive endosomes.
To further verify the role of LRP1 in apoE trafficking, we
transfected human full-length LRP1 fused to EGFP (LRP1-EGFP)
[31]. In order to achieve sufficient transfection rates with the 20 kb
full-length LRP1 plasmid vector, HEK293 cells were used.
Western blot analysis from transfected cells utilizing an antibody
against the extracellular region of the 85 kDa LRP1 subunit
distant to cytoplasmic fusion with EGFP, confirmed expression of
ectopically expressed LRP1-EGFP fusion protein (Fig. 5A).
Unprocessed endogenous and overexpressed LRP1 protein can
be detected at approximately 515 and 600 kDa, respectively.
Notably, the antibody revealed the presence of the small
endogenous 85 kDa LRP1 and higher amounts of the 115 kD
LRP1-EGFP subunit indicating furin cleavage [32] and appro-
priate processing of not only endogenous LRP1, but also the
LRP1-EGFP fusion protein. Using an antibody against the
515 kDa subunit showed low levels of endogenous LRP1 protein,
while considerable expression of the LRP1-EGFP fusion protein is
detected (Fig. 5B). LRP1 deficiency correlates with elevated LDLR
levels in liver of knockout mice [6], vice versa we observed minor
reductions in LDLR protein levels upon ectopic LRP1 expression
(Fig. 5C). Co-localization of LRP1-EGFP with cellular markers
confirmed predominant localization of LRP1-EGFP in EEA1-
positive endocytic compartments in HEK293 cells (data not
shown). In support of the results described above (Fig. 4A–C)
overexpression of LRP1-EGFP in HEK293 cells followed by a
30 min incubation with Cy3-apoE-TRL resulted in a strong
colocalisation of LRP1 and internalized apoE in endocytic
compartments (Fig. 5D–F).
To gain initial insights into LRP1-dependent sorting events in
endosomes, we next compared the trafficking of Cy3-RAP and
Cy3-apoE-TRL by confocal live-imaging (Fig. 5G–H). Video
microscopy of LRP1-EGFP positive vesicles incubated with Cy3-
RAP (Fig. 5G) or Cy3-apoE-TRL (Fig. 5H) for 30 min initially
revealed the presence of small LRP1-containing vesicles (data not
shown) followed by the fast appearance of Cy3-RAP in larger
LRP1 endosomes, which were in average up to 1 mm in diameter.
In agreement with the lysosomal trafficking of RAP, we observed a
significant proportion of Cy3-RAP in vesicles not containing
LRP1-EGFP. Furthermore, fluorescently-labelled RAP was absent
from the lumen but associated with the inner leaflet of the
endocytic, LRP1-EGFP positive membrane (see inlet in Fig. 5G),
suggesting tight binding of RAP to LRP1 prior to their dissociation
at later stages of the endocytic degradative pathway. Importantly,
prominent differences were revealed when comparing apoE and
RAP signals in LRP1-EGFP vesicles. While similar to Cy3-RAP,
fluorescently labelled apoE-TRL rapidly appeared in large LRP1-
containing endosomes; Cy3-apoE was found exclusively inside
LRP1-EGFP positive vesicles in an evenly distributed fashion
(Fig. 5H). These findings indicate LRP1-dependent differential
ligand sorting and accumulation of apoE in peripheral early
endosomes that prevent lysosomal targeting of endocytosed apoE.
LRP1 influences the recycling rate of apoE
Upon HDL-induced apoE recycling, apoE no longer colocalizes
with LRP1 but is found together with HDL (Fig. 6A–F). Live-
imaging confirmed that apoE leaves the LRP1-vesicles in the
presence of HDL (Fig. 6G–I). Thus, HDL stimulates the exit of
apoE from LRP1- containing endosomes which leads to the
intracellular association of apoE with HDL.
To quantify the involvement of LRP1 for HDL-induced apoE
recycling, HEK293 cells expressing EGFP or LRP1-EGFP were
incubated with Cy3-apoE-TRL for 60 min. Cell surface bound
Figure 2. TRL-derived apoE is internalized into peripheral endosomal compartments. Cy5-apoE-TRL and Cy3-RAP were prepared and
protein labelling was analyzed by SDS-PAGE and subsequent in-gel fluorescence detection (A). Incubation of HuH7 cells without (B) and with Cy5-
apoE-TRL (C) for 30 min at 37uC resulted in a punctuated endosomal pattern indicating receptor-mediated endocytosis. Nuclei were visualized by
DAPI and appear in blue. Bar is 20 mm.
doi:10.1371/journal.pone.0029385.g002
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an additional incubation 6 HDL3 for 60 min. The amount of
recycled Cy3-apoE was determined by SDS-PAGE of the chase
media and subsequent in-gel fluorescence quantification (Fig. 7).
Consistent with previous results [17], addition of HDL3 stimulated
the recycling of Cy3-apoE two-fold compared to the control cells
(Fig. 7A, lane 2 vs. 1). Importantly, the expression of LRP1-EGFP
enhanced the HDL-induced recycling of Cy3-apoE (Fig. 7A, lane
4 vs. 2). In contrast, RNAi-mediated LRP1 knock-down [31] in
HEK293 cells led to a decrease in HDL-induced apoE recycling
(Fig. 7B). ApoE recycling in LRP1-EGFP and LRP1 knock-down
cells was quantified in comparison to EGFP-transfected controls
(Fig. 7C). The comparison of basal and HDL-dependent recycling
revealed that LRP1-EGFP expression promoted HDL-induced
apoE recycling (gray columns, approximately 40% increase) while
LRP1 knock-down resulted in a 20% reduction in apoE recycling
(white columns).
The quantitative role of LRP1 for apoE recycling was further
evaluated in primary murine hepatocytes (Fig. 8). LRP1flox mice
[6] were treated with an adenovirus encoding the Cre-recombi-
nase (AdCre) in order to preclude hepatic LRP1 expression.
Control animals were injected with a virus expressing EGFP
(AdEGFP). Primary hepatocytes were prepared from both mice
three days after infection, and Western blotting (Fig. 8A) and
indirect immunofluorescence using an antibody against the
515 kDa LRP1 subunit (Fig. 8B–C) demonstrated the efficient
knock-down of LRP1 expression in hepatocytes isolated from
AdCre-treated mice. Importantly, the amount of basal, and even
more pronounced, HDL-induced apoE-recycling was significantly
reduced in LRP1
2/2 cells (Fig. 8D–E). Taken together, while
LRP1 knockdown lead to a decreased apoE recycling, the
overexpression of LRP1 stimulated HDL-induced apoE recycling
indicating that LRP1 expression correlated with apoE recycling
efficiency.
Discussion
The aim of the present study was to investigate the role of LRP1
for the intracellular targeting and recycling of apoE. Here we
demonstrate that LRP1 strongly contributes to the retention and
storage of apoE in early endosomes. Furthermore, LRP1
significantly reduces the delivery of apoE to the lysosomal
compartment and prevents apoE degradation (Figs. 1–4). ApoE
bound to LRP1 within early endosomes can be mobilized by HDL
Figure 3. Internalized TRL-derived apoE co-localizes with LRP1 in EEA1-positive endosomes. HuH7 cells were incubated with Cy5-apoE-
TRL for 10 min at 37uC. As indicated by the arrows, subsequent immunofluorescence analysis revealed co-localization of apoE (A) with LRP1 (B) in
EEA1-positive endosomes (C). The merged image is shown in D. Nuclei were visualized by DAPI and appear in blue. Bar is 20 mm.
doi:10.1371/journal.pone.0029385.g003
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contain HDL but not LRP1 (Fig. 5). As reported earlier, this
process includes the temporary uptake of HDL and the association
of recycled apoE with internalized HDL in early endosomes [17].
In contrast to apoE, which is trapped in LRP1-endosomes (Figs. 3,
4), RAP followed the lysosomal degradative pathway after
lipoprotein receptor-mediated endocytosis (Fig. 4; [15,27,33]).
LRP2 (originally described as Megalin or gp330) is very similar
to LRP1; it has a comparable molecular weight and also efficiently
internalizes RAP [34]. LRP2 is expressed on the apical surfaces of
absorptive epithelia including the yolk sac and the renal proximal
tubules [35]. Czekay et al. presented a detailed analysis of the
intracellular pathway and the sorting mechanisms of RAP after
LRP2-mediated uptake [33]. The authors investigated the
internalization of LRP2/RAP complexes and described the
recycling of LRP2 to the cell surface, which in contrast to most
other recycling receptors, including the LDL receptor family
members, occurs from late endosomes. In these studies the pH-
dependent release of the ligand appears to trigger the recycling of
the receptor and since the LRP2/RAP association is rather pH-
resistant, recycling occurs only at pH-values as low as in late
endosomes. Here we show that similar to the LRP2/RAP
complex, RAP remains bound to LRP1 at this point before its
subsequent targeting to late endosomal compartments (Figs. 4, 5).
In contrast, apoE under the same experimental conditions is
released into the vesicular lumen (Fig. 5H) and is stored in LRP1-
positive endosomes. Furthermore, both the RNAi-mediated down-
regulation of LRP1 (Fig. 7) and the absence of LRP1 in primary
murine hepatocytes (Fig. 8) resulted in decreased apoE recycling.
Vice versa, LRP1 overexpression led to an enhanced HDL-
induced apoE recycling (Fig. 7), indicating that LRP1 is most
probably responsible for the differential intracellular targeting and
recycling of internalized apoE. For the postprandial lipoprotein
metabolism, this mechanism meets the physiological demands for
an efficient uptake of TRL after a lipid-rich meal. Since TRL
depend on apoE for an LRP1-mediated uptake into the liver, the
HDL-bound apoE plasma pool is heavily used to transfer apoE to
nascent TRL. The recycling of internalized apoE can be a
valuable source for immediate replenishment [3]. The mechanistic
fundament for a quick response of such a system is achieved by (a)
the direct re-association of apoE with apoE-poor HDL during the
recycling process and by (b) a short intracellular recycling route
close to the plasma membrane, which only comprises early
endosomes.
The physiological importance of intracellular LRP1-apoE
storage and subsequent apoE recycling could also imply LRP1-
dependent signal transduction pathways. Beyond endocytosis
LRP1 regulates diverse cellular processes, for instance PDGF
and Wnt-dependent signalling pathways, in an apoE-dependent
manner [36–38]. These processes could be modified by apoE-
Figure 4. Internalized RAP but not TRL-derived apoE is sorted towards lysosomes. Incubation of HuH7 cells with Cy5-apoE-TRL or Cy3-RAP
was performed for 30 min at 37uC. Subsequent confocal immunofluorescence analysis revealed colocalization of LRP1 with apoE (A–B, see arrows in
merged image C). Internalized Cy3-apoE did not appear within lysosomes as indicated by a counterstain with LAMP-1 (D–F). In contrast, after 30 min
Cy3-RAP co-localized with LAMP-1 (G–H, see arrows in the merged image I), indicating lysosomal targeting of the LRP1 ligand RAP. Nuclei were
visualized by DAPI and appear in blue. Bar is 20 mm.
doi:10.1371/journal.pone.0029385.g004
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be a regulatory component of this signal transduction machinery.
Hence this study might point to a novel concept in which apoE-
mediated intracellular sequestration of lipoprotein receptors
modulate their functions in regulating lipoprotein levels in the
liver and signal transduction processes in peripheral tissues such
as the central nervous system. In line with this hypothesis, it has
recently been demonstrated that apoE isoforms differently
Figure 5. LRP1-dependent sorting of apoE and RAP. Cell lysates from EGFP (lane 1 in A, B and C) or LRP1-EGFP (lane 2 in A, B and C) transfected
cells were subjected to SDS-PAGE, and Western blotting was performed with antibodies against the 85 kDa subunit of LRP1 (A), the 515 kDa subunit
of LRP1 (B) and the LDLR (C). The endogenous LRP1 precursor protein is cleaved by furin into 515 kDa and 85 kDa fragments (shown in lane 1 of A
and B). The recombinant LRP-EGFP can be detected at approximately 600 kDa (lane 2 in A and B) and for the cleaved 85 kDa fragment fused to EGFP
at 115 kDa (LRP185-EGFP; lane 2 in A). The overexpression of LRP1-EGFP expression slightly reduced the expression of LDLR (C). Western blotting
using an antibody against beta actin verified equal protein loading. LRP1-EGFP transfected HEK293 cells were incubated with Cy3-apoE-TRL for
30 min. Confocal microscopy revealed strong colocalization of LRP1-EGFP and Cy3-apoE in endosomal compartments (D–E; see arrows in panel F;
nuclei are stained with DAPI). High-magnification confocal live-cell microscopy of LRP1-EGFP expressing cells incubated with Cy3-RAP (G) or Cy3-
apoE-TRL (H) revealed that RAP is still attached to the inner leaflet of the vesicular membrane and does not diffuse freely within the lumen (G, arrows
and inlet). Additionally, RAP was detected in small, dense vesicles not containing LRP1 (G, arrowheads). In contrast, apoE was only present within
LRP1-EGFP endosomes and evenly distributed inside the lumen (H, arrows). Bar is 5 (G–H) and 20 mm (D–F), respectively.
doi:10.1371/journal.pone.0029385.g005
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LDL receptor family member, via apoER2 sequestration within
intracellular compartments [39]. ApoE is a major susceptibility
gene for the late onset of Alzheimer in which individuals with an
apoE4 allele show an increased risk and an earlier onset of the
disease. Chen et al. showed that impaired recycling of the apoE4
isoform in neuronal cells and in mice expressing the human
apoE4 gene results in the trapping of postsynaptic ApoER2. As a
consequence ApoER2 surface expression is reduced, which
impairs NMDA receptor-mediated neurotransmission in apoE4
knock-in mice. Together with our study these findings point to
a novel mechanism in which apoE-mediated intracellular
sequestration of lipoprotein receptors modulate their respective
functions.
The results of our current work are summarized in Figure 9.
Internalized RAP remains bound to LRP1 in early endosomes and
is not released into the vesicular lumen. Once LRP1/RAP
complexes arrive in late endosomes, they dissociate. LRP1 then
returns to the plasma membrane while RAP is targeted to the
lysosome. The uptake and trafficking of CR/apoE is strikingly
different: LRP1 binds apoE, the particle disassembles after the
uptake and the lipid core travels along early and late endosomes to
the lysosome [13,15]. ApoE is already released into the vesicular
lumen and accumulates in LRP1-positive storage vesicles thereby
escaping the degradation pathway. After the induction of
recycling, apoE is immediately separated from LRP1 in early
endosomes to re-associate with temporarily internalized HDL.
Materials and Methods
Antibodies and Reagents
Paraformaldehyde (PFA), glycine and BSA were purchased
from Sigma. Mowiol was purchased from Calbiochem. DMEM,
PBS, FCS, trypsin, penicillin and streptomycin were from
Invitrogen (Gibco). Heparin (Liquemin) was purchased from
Roche. Following antibodies were used: monoclonal antibody
against EEA1 and LAMP-1 (BD Biosciences), monoclonal
antibody against G58K and beta-actin (Sigma), anti-LRP1 (8G1
and 8B8; Progen) anti-LDLR (Progen), Cy2-conjugated donkey
anti-rabbit F(ab9)2 fragments, Cy3-conjugated donkey anti-mouse
F(ab9)2 fragments, Cy3-conjugated donkey anti-chicken F(ab9)2
fragments and horseradish peroxidase-conjugated goat anti-rabbit
F(ab9)2 fragments were purchased from Jackson Immuno
Research. Cy3 and Cy5 fluorescence protein labeling kit were
from Amersham Biosciences.
Cell culture and transfection
Human hepatoma cells (HuH7) and human embryo kidney
(HEK-293) were grown in DMEM supplemented with 10% FCS
and penicillin/streptomycin at 37uCi n5 %C O 2. To mediate
LRP1 down-regulation and the transient expression of human
recombinant LRP1 fused to the enhanced green fluorescent
protein (LRP1-EGFP), HEK-293 were transfected in 6-wells using
FuGENE 6 (Roche) as described [31]. To obtain LRP1-deficient
and LRP1-expressing primary hepatocytes, LRP1flox mice (kindly
Figure 6. HDL stimulates the exit of apoE from LRP1- containing endosomes. HuH7 cells were incubated with Cy5-apoE-TRL for 20 minutes.
ApoE recycling was then induced by Cy3-HDL. After 5 min (A–C) and 15 min (D–F), LRP1 (arrows) did no longer co-localize with Cy5-apoE which was
instead found associated with Cy3-HDL (arrowheads; nuclei in blue). This was confirmed by high-magnification video-microscopy of LRP1-EGFP
expressing HEK293 cells (G–I; due to short time-lapse between acquisition of red and blue channels, a minor signal offset due to endosomal
movements was observed). Bar is 5 (G–I) and 20 mm (A–F), respectively.
doi:10.1371/journal.pone.0029385.g006
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2.5?10
9 IFU of an adenovirus expressing Cre recombinase
(AdCre) or EGFP (AdEGFP), respectively. Primary mouse
hepatocytes were prepared by liver perfusion, EDTA dissociation
and centrifugation on a self-generating percoll gradient three days
after infection as described [40]. Animal experiments were done in
accordance with the guidelines of the Federation of American
Societies for Experimental Biology (FASEB) and approved by the
Department of Veterinary Affairs of the State of Hamburg.
Ligand preparation
Recombinant RAP [41], apoE-deprived HDL3 (d=1.125–
1.21 g/ml) from normal healthy donors [17] and TRL from an
apoCII-deficient patient were isolated as described [23]. Human
recombinant apoE3 were expressed in BL21 Escherichia coli and
purified by gel filtration chromatography. For immunofluorescence,
0.5 mg RAP was labelled with Cy3 to obtain Cy3-RAP. To obtain
Cy3-apoE-TRL or Cy5-apoE-TRL, 100 mg of recombinant apoE3
were labelled with Cy3 or Cy5, respectively. Association of
fluorescent labelled apoE with TRL was allowed for 60 min at
37uC and then Cy3-apoE-TRL or Cy5-apoE-TRL were re-isolated
by ultracentrifugation. Fluorescent label was exclusively found in
apoE as determined by SDS-PAGE followed by in-gel fluorescence
analysis (see below). HDL3 apolipoproteins (1 mg) were labelled
with Cy3 (Cy3-HDL) or Cy5 (Cy5-HDL) as described [17].
Fluorescent label was found predominantly in apoA-I (,90–95%)
as determined by SDS-PAGE, respectively (data not shown).
Immunofluorescence and recycling experiments
For immunofluorescence experiments, human hepatoma cells
were washed in PBS, fixed in 4% PFA and indirect immun-
fluorescence against LRP1 (polyclonal 377-4 provided by J. Herz,
Dallas), LDLR, LAMP-1, G58K and EEA1 was performed. To
analyse endocytosis, hepatoma cells were incubated with Cy3-
apoE-TRL or Cy5-apoE-TRL (5 mg/ml) in DMEM+2% BSA at
37uC for 10 min or 30 min, respectively. Prior to fixation with 4%
PFA, cells were washed in DMEM and cell surface-bound material
was released by heparin treatment for 10 min at 4uC. To analyse
intracellular targeting and recycling of apoE-TRL, hepatoma cells,
transfected HEK-293 cells or primary hepatocytes were first
incubated with Cy3-apoE-TRL or Cy5-apoE-TRL (5 mg/ml) in
DMEM+2% BSA for 30 min at 37uC. Cells were washed in
DMEM and treated with heparin for 10 min. To follow apoE
recycling, cells were incubated for additional 0–60 min at 37uCi n
DMEM (0.1% BSA) 620 mg/ml unlabeled or fluorescent-labelled
HDL3 (Cy3-HDL3, Cy5-HDL3). Supernatants were harvested and
processed as described below while cells were prepared for indirect
immunofluorescence (see above). Confocal images were taken
using a Zeiss LSM 510 (software version 3.0). For living cell
microscopy, LRP1-EGFP expressing HEK-293 cells were incu-
bated with Cy3-apoE-TRL, Cy5-apoE-TRL (5 mg/ml) or Cy3-
RAP (10 mg/ml) in DMEM+2% BSA for 0–30 min at 37uC. To
visualize HDL transport during apoE recycling, Cy3-apoE-TRL
incubated cells were washed in DMEM and incubated for
additional 0–30 min with 20 mg/ml Cy5-HDL3. Confocal images
were taken every minute in the multitrack mode using optimized
pinhole adjustment for each fluorochrome.
SDS-PAGE, Western blot and protein quantification
To analyze the labelling of ligands, 10 mg of fluorescent RAP,
HDL and apoE-TRL were separated by SDS-PAGE on 4–12%
gradient gels (NuPAGEH, Invitrogen). Visualization was per-
formed by in-gel scanning with the Typhoon 9410 (Amersham).
To analyse lipoprotein receptor expression, cells were lysed in cell
Figure 7. LRP1-dependent apoE recycling. HEK293 cells were
transfected with pFB-LRP-EGFP, an shRNA vector against LRP1 or EGFP
as control [31]. Pulse-chase experiments were performed by incubating
HEK293 cells with Cy3-apoE-TRL for 60 min at 37uC. Cells were washed
with heparin and incubated for additional 60 min at 37uC with media in
the presence or absence of 20 mg/ml HDL3. Then cell culture media
were harvested and the amount of re-secreted Cy3-apoE was
determined by SDS-PAGE and subsequent in-gel fluorescence detec-
tion. The position of apoE is indicated. Representative gels with the
corresponding apoE bands are shown for LRP1-EGFP overexpression (A)
and reduced LRP1 expression (B). The highest and lowest intensity in
each gel is represented as maximum black and white, respectively;
therefore only intra-gel comparisons were performed. The quantifica-
tion of these experiments is shown as percent recycling versus the
corresponding mock transfected cells, which was set to 100% in order
to ensure a valid comparison of the changes in apoE recycling between
the different experiments (C). *: p,0.05, **: p,0.01 for Student’s t-test
(n$4) 6 S.E.M.
doi:10.1371/journal.pone.0029385.g007
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2/2 primary hepatocytes. LRP1flox mice were infected with AdEGFP or AdCre and three days
after infection primary hepatocytes were isolated. Sixteen hours after seeding, the infection with AdCre resulted in a dramatic loss of LRP1 protein
expression as determined by Western blotting (A) and indirect immunofluorescence (B–C). Pulse-chase experiments were performed by incubating
LRP1-positive (LRP
+/+) and LRP1–negative (LRP
2/2) hepatocytes with Cy3-apoE-TRL for 60 min at 37uC. Cells were washed with heparin and
incubated for additional 60 min at 37uC with media in the presence or absence (w/o) of 20 mg/ml HDL3. Then supernatants were harvested and the
amount of re-secreted Cy3-apoE was determined by SDS-PAGE and subsequent quantification as described above. HDL-induced apoE recycling was
reduced in LRP1
2/2 cells as seen by in-gel fluorescence of chase media (D). Quantification of 4 independent experiments 6 S.E.M. revealed a strong
reduction of HDL-induced apoE recycling in LRP1
2/2 hepatocytes 6 HDL (E).
doi:10.1371/journal.pone.0029385.g008
Figure 9. Model of LRP1-dependent uptake and apoE recycling. Left: RAP is internalized by LRP1, remains associated with the receptor in
early endosomes and dissociates in late endosomes, from which LRP1 recycles back to the plasma membrane. RAP is degraded in the lysosome.
Right: apoE-TRL are taken up by LRP1 via apoE and disintegrate in early endosomes. While apoE remains in early endosomes and LRP1 recycles back
to the PM, the core particle is targeted to the lysosome. Upon stimulation with HDL, apoE separates from LRP1 and re-associates with HDL in early
endosomes prior to re-secretion. See text for further details.
doi:10.1371/journal.pone.0029385.g009
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50 mM Tris/HCl, pH 8.0) and were analyzed using 4–12%
gradient gels (Invitrogen). The expression of LRP1-EGFP in
transfected HEK-293 cells was visualized by in-gel fluorescence
detection. For western blotting, proteins were separated by SDS-
PAGE in 4–12% gradient gels (Invitrogen), transferred to
nitrocellulose and incubated with specific antibodies against
different subunits of LRP1 (Progen, [15]), LDLR (Progen) and
beta-actin (Sigma). The respective secondary horseradish perox-
idase-labeled antibodies were from Jackson ImmunoResearch and
signals were detected with enhanced chemiluminescence (ECL).
For the quantification of apoE recycling, transfected HEK-293
cells or primary hepatocytes were incubated with fluorescent
labelled apoE-TRL (1 mg/ml) for 60 min at 37uC, washed and
incubated for additional 60 min at 37uC+/220 mg/ml HDL3 in
DMEM+0.1% BSA. The media were harvested, filtered (0.45 mm)
and cleared by centrifugation at 14,000 g for 10 min. The
supernatants were analyzed on 4–12% gradient gels and
fluorescence-based in-gel quantification was performed by scan-
ning with the Typhoon 9410 and analysis with the software
ImageQuant 5.2 and/or FluorSep 2.2 (Molecular Dynamics).
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